Suchergebnisse - "Bertulli, Rossella"

PubPharm (6)

1

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

2

EURO-B.O.S.S. : A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

enthalten in: Tumori | 2018

von Ferrari, S. | Bielack, S. | Smeland, S. | +30

3

Epithelioid sarcoma : prognostic factors and survival in a series of patients treated at a single institution

enthalten in: Annals of surgical oncology | 2007

von Baratti, D. | Pennacchioli, E. | Casali, P. | +7

4

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors : a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2005

von Van Glabbeke, M. | Verweij, J. | Casali, P. | +11

5

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib : randomised trial

enthalten in: Lancet (London, England) | 2004

von Verweij, J. | Casali, P. | Zalcberg, J. | +9

CommentIn: Lancet. 2004 Sep 25-Oct 1;364(9440):1101-2. - PMID 15451202

6

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion

enthalten in: Journal of surgical oncology | 2003

von Deraco, M. | Casali, P. | Inglese, M. | +4

1
[1]